Z., uran, N., trbe, S., Zorii, Z., Filipi, I., Brei, P., Seiverth, S., & Sikiri, P
Some patients need weekly injections at first, then switch to monthly maintenance based on lab levels and symptoms
A supplier that sources its API from a facility with a recent FDA warning letter is a supply risk regardless of what its finished product price is
Diet-related factors, physical activity, and weight status in Polish adults
FDA in December 2017 and is currently on the market in many countries and regions around the world
For many patients, tirzepatide will continue to be an effective treatment for managing blood sugar levels and promoting weight loss